Literature DB >> 6603231

The effect of alcoholic cirrhosis on the activities of microsomal aldrin epoxidase, 7-ethoxycoumarin O-de-ethylase and epoxide hydrolase, and on the concentrations of reduced glutathione in human liver.

K W Woodhouse, F M Williams, E Mutch, P Wright, O F James, M D Rawlins.   

Abstract

Activities of the microsomal mono-oxygenases 7-ethoxycoumarin O-de-ethylase (EOC) and aldrin epoxidase (AE), together with microsomal epoxide hydrolase (EH) activity and concentrations of reduced glutathione (GSH) have been measured in liver from patients with alcoholic cirrhosis and in normals. Activities of both mono-oxygenases were significantly reduced in alcoholic cirrhosis. EOC activity (pmol 7-OH coumarin formed/mg microsomal protein/min) was 108.0 +/- 10.6 (n = 8) in normals and 60.9 +/- 11.6 (n = 8) in alcoholic cirrhosis (P less than 0.01). AE activity (pmol dieldrin formed/mg microsomal protein/min) was 58.9 +/- 9.5 (n = 11) in normal liver biopsies and 29.9 +/- 8.6 (n = 9) in alcoholic cirrhosis (P less than 0.05). Microsomal EH activity (nmol styrene glycol formed/mg microsomal protein/min) was similar in normals (39.2 +/- 4.4, n = 11) and alcoholic cirrhosis (40.5 +/- 9.1, n = 6). GSH concentrations (microgram GSH/g liver tissue) were lower (P less than 0.01) in alcoholic cirrhosis (792 +/- 73, n = 10) compared to normals (1182 +/- 76, n = 6).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603231      PMCID: PMC1427935          DOI: 10.1111/j.1365-2125.1983.tb01547.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  A fluorometric method for determination of oxidized and reduced glutathione in tissues.

Authors:  P J Hissin; R Hilf
Journal:  Anal Biochem       Date:  1976-07       Impact factor: 3.365

2.  Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.

Authors:  P J Johnson; N Krasner; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

Review 3.  Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules.

Authors:  E C Miller; J A Miller
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

Review 4.  The metabolic activation of chemical carcinogens.

Authors:  P Sims
Journal:  Br Med Bull       Date:  1980-01       Impact factor: 4.291

5.  An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  W F Greenlee; A Poland
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

6.  Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes.

Authors:  G C Farrell; W G Cooksley; L W Powell
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

7.  Purification and specificity of a human microsomal epoxide hydratase.

Authors:  F Oesch
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

8.  Effect of acute and chronic ethanol ingestion on the content of reduced glutathione of various tissues of the rat.

Authors:  V Fernández; L A Videla
Journal:  Experientia       Date:  1981-04-15

9.  Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.

Authors:  A R Boobis; M J Brodie; G C Kahn; D R Fletcher; J H Saunders; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

10.  Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent mono-oxygenase activities.

Authors:  T Wolff; E Deml; H Wanders
Journal:  Drug Metab Dispos       Date:  1979 Sep-Oct       Impact factor: 3.922

View more
  6 in total

1.  Comparison of in vitro and in vivo biotransformation in patients with liver disease of differing severity.

Authors:  H Kraul; J Truckenbrodt; A Huster; R Töpfer; A Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Conjugation pathways in liver disease.

Authors:  G M Pacifici; A Viani; M Franchi; S Santerini; A Temellini; L Giuliani; M Carrai
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

3.  Ethoxyresorufin O-deethylation by human liver microsomes.

Authors:  F M Williams; E Mutch; K W Woodhouse; D Lambert; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

4.  7-Ethoxyresorufin deethylase (EROD) in human liver--the effect of alcoholic liver disease.

Authors:  K W Woodhouse; E Mutch; F M Williams; O F James; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver.

Authors:  K W Woodhouse; F M Williams; E Mutch; P Wright; O F James; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  The metabolism of 7-ethoxycoumarin in human liver microsomes and the effect of primary biliary cirrhosis: implications for studies of drug metabolism in liver disease.

Authors:  K W Woodhouse; H C Mitchison; E Mutch; P D Wright; M D Rawlins; O F James
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.